New Evidence of Possible Contagious Spread of Alzheimer’s Disease

New Evidence of Possible Contagious Spread of Alzheimer’s Disease

Article
Brain & Nerve
Behavioral & Mental Health
+1
Contributed byMaulik P. Purohit MD MPHSep 16, 2015

Diseases like Mad Cow, Kuru, and Creutzfeldt-Jakob are caused by misfolded proteins called prions, which propagate by inducing misfolding in normal proteins and cause human to human transmission, when people come in contact with infected brain tissue. Misfolded proteins cause neuronal death due to increased aggregation. Neuronal cell death due to protein aggregation is also responsible for causing diseases like Parkinson's, ALS, and Alzheimer’s disease. However, there have been no reports thus far of human-to-human transmission of factors causing Parkinsons, Alzheimer’s, and ALS.

The scientists used to suspect that there would be a possibility of propagation of misfolded amyloid plaques in Alzheimer’s, similar to that occurring in prion disease. In some studies, when minute amounts of amyloid-beta material were injected into the brains of mice and monkeys, the injected material initiated a chain propagation reaction, leading to the development of full-scale Alzheimer’s disease in the animals.

Now, scientists have discovered possible first evidence for human-to-human transmission of the misfolded proteins of Alzheimer’s disease. Since minute amounts of the brain material may be transferred during neurological/ neurosurgical procedures by re-usage of surgical equipment or hormonal injections derived from brain tissue, the scientists at University College London investigated the presence of amyloid beta proteins in the brains of 8 individuals who died due to Creutzfeldt-Jakob disease. All these eight patients had developed Creutzfeldt-Jakob disease from receiving prion-contaminated growth hormone injections, derived from the pituitary gland extract of Creutzfeldt-Jakob disease individuals. They found that six out of eight individuals also had a widespread presence of amyloid beta proteins. These individuals were in the age group 36 to 51 years, which is too low for the appearance of beta-amyloid proteins in the brain, suggesting that the beta-amyloid material might have been transferred during prion transmission.

The results of the study open up the possibility of human-to-human or animal-to-human transmission of Alzheimer’s disease due to contact with brain tissue, or it may suggest another possibility of prions inducing beta amyloid aggregate formation in infected brains.  This study may have opened a can of worms and suggests a need for further investigation, in order to rule out contagious spread of Alzheimer’s disease, however, remote the possibility.

Written by Dr. Ashish Patil

Primary Reference

Jaunmuktane, Z., Mead, S., Ellis, M., Wadsworth, J., Nicoll, A., Kenny, J.,Brandner, S. (2015). Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature, 247-250.

DoveMed Resources

Parkinson's Disease (PD). (n.d.). Retrieved September 14, 2015, from http://www.dovemed.com/parkinsons-disease-pd/

Amyotrophic Lateral Sclerosis (ALS). (n.d.). Retrieved September 14, 2015, from http://www.dovemed.com/amyotrophic-lateral-sclerosis-als/

Alzheimer's Disease (AD). (n.d.). Retrieved September 14, 2015, from http://www.dovemed.com/alzheimers-disease-ad/

Additional References

Prusiner, S. (n.d.). Prions are novel infectious pathogens causing scrapie and creutzfeldt-Jakob disease. Bioessays, 281-286 

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!